结直肠癌微环境中的三级淋巴体结构:探索新的治疗点
Nan-Nan Dai1, Man-Yi Hu1, Jian-Ping Wang1
1Department of Colorectal and Anal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang Province, China.
Cancer immunology, immunotherapy : CII
|June 21, 2025
概括
三级淋巴体结构 (TLSs) 显示出改善结直肠癌 (CRC) 免疫疗法的希望. 这些免疫结构可以作为生物标志物和治疗点,以提高CRC患者的治疗疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫疗法在结直肠癌 (CRC) 中的疗效有限,这凸显了对新的治疗点的需求.
- 三级淋巴体结构 (TLS) 是免疫聚合物,在瘤微环境中模仿二级淋巴体器官.
- TLS 动态适应瘤微环境,通过细胞和细胞因子相互作用影响抗瘤免疫力.
研究的目的:
- 审查当前关于三级淋巴细胞结构 (TLSs) 作为结直肠癌 (CRC) 免疫治疗中的新疗法点的研究.
- 探索TLS作为免疫学标记物的潜力,以评估CRC中的免疫治疗结果.
主要方法:
- 在CRC免疫疗法中对TLS当前研究的文献综述.
- 分析表明TLS在调节CRC免疫微环境中的作用的研究.
- 检查TLS作为免疫治疗反应预测生物标志物的潜力.
主要成果:
- TLS的形成是动态的,并影响CRC的免疫状态.
- 在结直肠癌中,TLS可以增强免疫治疗的疗效.
- TLS可以作为预测免疫治疗结果的关键免疫学标记.
结论:
- 三级淋巴体结构 (TLS) 是一个有前途的新型治疗点,用于增强结直肠癌 (CRC) 免疫疗法.
- 进一步研究TLS机制及其在CRC中的作用是有必要的,以充分利用其治疗潜力.
- 在CRC免疫疗法中,TLS可以为患者分层和监测治疗反应提供有价值的生物标志物.
相关概念视频
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675